Cellectis S.A. (CMVLF)
OTCMKTS
· Delayed Price · Currency is USD
1.250
0.00 (0.00%)
At close: May 22, 2025
Cellectis Employees
As of December 31, 2024, Cellectis had 222 total employees, including 216 full-time and 6 part-time employees. The number of employees increased by 1 or 0.45% compared to the previous year.
Employees
222
Change (1Y)
1
Growth (1Y)
0.45%
Revenue / Employee
$249,986
Profits / Employee
-$276,402
Market Cap
111.54M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Cellectis News
- 9 days ago - Cellectis' Annual Shareholders General Meeting to be Held on June 26, 2025 - GlobeNewsWire
- 15 days ago - Cellectis: Partnerships And Promised Data In 2025 Continue To Justify The Buy - Seeking Alpha
- 18 days ago - Cellectis Non-GAAP EPS of -$0.17, revenue of $12M misses by $1.83M - Seeking Alpha
- 18 days ago - Cellectis Reports Financial Results for the First Quarter 2025 - GlobeNewsWire
- 21 days ago - Cellectis Q1 2025 Earnings Preview - Seeking Alpha
- 24 days ago - Cellectis to Report First Quarter Financial Results on May 12, 2025 - GlobeNewsWire
- 4 weeks ago - Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting - GlobeNewsWire
- 2 months ago - Cellectis S.A. (CLLS) Q4 2024 Earnings Call Transcript - Seeking Alpha